Cross Sectional CFAR HIV/COVID-19 Study

The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of Miami Miller School of Medicine.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

SARS-CoV Infection COVID-19 Coronaviridae Infections Coronavirus Infections Covid19 Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Severe Acute Respiratory Syndrome Virus Diseases

Age range

3 year–25 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Batchelor's Children's Research Institute

Miami, Florida, 33136, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Being a patient to the Pediatric or Adolescent clinic located at Batchelor Children Research Institute (BCRI)
Being diagnosed with HIV infection by the time of enrollment
At enrollment, 3 to < 26 years

Exclusion criteria

Patient will be excluded from the study if any of the following are identified:
Patients under legal age and in the State's custody
Participant or legal guardian unable to sign Informed Consent forms
Participant unable to complete study visits

Treatment and study plan

Primary outcomes

Number of participants who tested positive with SARS COV-2 Infection

Time frame: month 3

SARS COV-2 Infection will be analyzed from nasopharyngeal swab samples via RT-PCR assay
Number of participants who tested positive with SARS COV-2 antibody

Time frame: month 3

SARS COV-2 antibody will be analyzed from blood samples via serological assay

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Collaborators

Miami Center for AIDS Research (CFAR)

Registry information

Official study title

Cross Sectional Survey Of Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (COV-2) Infection And Seroprevalence In A Cohort Of HIV-Infected Children, Youth, And Adolescents

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Aug 14, 2020
Registry last updated: Mar 23, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed